Abstract
The establishment of human embryonic stem cell (hESC) lines, as well as the recent induced pluripotent stem cells (hiPSC), has greatly expanded our knowledge about the early development in human ontogeny. In the past decade, hESCs and hiPSCs have been proven excellent tools in characterization of molecular and cellular mechanisms underlying the normal and diseased differentiation of hematopoietic progenitors and mature, functional blood cells. Most of the types of hematopoietic cells (HCs) derived from hESCs have recently been shown with functionally mature properties, including erythrocytes, neutrophils, platelets, megakaryocytes, eosinophils, monocytes, dendritic cells (DC), nature killer (NK) cells, mast cells (MCs), and B- and T-lineage lymphoid cells. Along with the advances in research, a clinical translation of hESC/hiPSC-derived HCs as novel therapies is foreseen in the near future. However, different efficiencies in blood cell production have been reported when using different culture systems. Because of the restriction to use living human embryos, most of the hematopoiesis-inducing cultures are based on murine stromal cells. In our laboratory, we established efficient blood cell-inducing systems by coculturing hESC/hiPSCs with murine fetal stromal cells derived from aorta-gonad-mesonephros (AGM) region and fetal livers. These fetal hematopoietic tissue-derived cells showed strong supporting effects on hESC/hiPSCs, gradually inducing them to terminally mature blood cells if given proper conditions. The murine fetal hematopoietic tissue-derived stromal cells, AGM stromal cells [Xu M et al. Blood 92:2032–2040, 1998], and mid-gestation fetal liver stromal cells [Ma F et al. Blood 97:3755–3762, 2001; Ma F et al. Proc Natl Acad Sci USA 105:13087–13092, 2008] are maintained in our laboratory and radiated right before coculture. When undifferentiated hESC/hiPSC colonies are plated on these stromal cells, they grow up and differentiate to, firstly, a mesoderm-like structure. On days 10–14 in cocultures, some floating cells free themselves from the adherent layer, and they are characterized as hematopoietic progenitor cells. In the second culture system, these hematopoietic progenitors are further induced along to a specific blood cell lineage, such as erythrocytes, MCs, eosinophils, etc. At certain time points, these hESC/hiPSC-derived blood cells are examined with maturity and function. In this chapter, we will describe a coculture protocol developed in our laboratory for differentiating hESC/hiPSCs into hematopoietic cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Xu M, Tsuji K, Ueda T. et al. (1998) Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood 92, 2032–2040.
Ma F, Wada M, Yoshino H. et al. (2001) Development of human lymphohematopoietic stem and progenitor cells defined by expression of CD34 and CD81, Blood 97, 3755–3762.
Ma F, Ebihara Y, Umeda K. et al. (2008) Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc Natl Acad Sci USA 105, 13087–13092.
Thomson JA, Itskovitz-Eldor J, Shapiro SS. et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282,1145–1147.
Bongso A, Fong CY, Ng SC, et al. (1994) Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod 9,2110–2117.
Reubinoff BE, Pera MF, Fong CY, et al. (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18,399–404.
Takahashi K, Tanabe K, Ohnuki M.et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872.
Yu J, Vodyanik MA, Smuga-Otto K, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318,1917–1920.
Park IH, Zhao R, West JA, et al. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451,141–146.
Hanna J, Wernig M, Markoulaki S, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920–1923.
Wernig M, Zhao JP, Pruszak J, et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci USA 105, 5856–5861.
Dimos JT, Rodolfa KT, Niakan KK, et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221.
Sakamoto H, Tsuji-Tamura K, Ogawa M, et al. (2010) Hematopoiesis from pluripotent stem cell lines. Int J Hematol 91, 384–391.
Nakano T, Kodama H, Honjo T. (1994) Generation of Lymphohematopoietic Cells from Embryonic Stem Cells in Culture. Science 265, 1098–1101.
Mukouyama Y, Hara T, Xu M. et al. (1998) In Vitro Expansion of Murine Multipotential Hematopoietic Progenitors from the Embryonic Aorta–Gonad–Mesonephros Region. Immunity 8, 105–114.
Slukvin II, Vodyanik MA, Thomson JA, et al. (2006) Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol 176, 2924–32.
Umeda K, Heike T, Yoshimoto M, et al. (2004) Development of primitive and definitive hematopoiesis from non-human primate embryonic stem cells in vitro. Development 131, 1869–1879.
Gaur M, Kamata T, Wang S, et al. (2006) Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost 4, 436–442.
Takayama N, Nishikii H, Usui J.et al. (2008) Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs. VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298–5306.
Timmermans F, Velghe I, Vanwalleghem L.et al. (2009) Generation of T Cells from Human Embryonic Stem Cell-Derived Hematopoietic Zones. J Immunol 182, 6879–6888.
Ma F, Kambe N, Wang D, et al. (2008) Direct development of functionally mature tryptase/chymase double-positive connective tissue-type mast cells from primate embryonic stem cells. Stem Cells 26, 706–714.
Ma F, Wang D, Hanada S, et al. (2007) Novel Method for Efficient Production of Multipotential Hematopoietic Progenitors from Human Embryonic Stem Cells. Int J Hematol 85, 371–379.
Nakahata T, Ogawa M. (1982) Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest 70, 1324–1328.
Nakahata T, Spicer SS, Cantey JR, Ogawa M. (1982) Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood 60, 352–361.
Nakahata T, Ogawa M. (1982) Identification in culture of a class of hemopoietic colony-forming units with extensive capability to self-renew and generate multipotential hemopoietic colonies. Proc Natl Acad Sci USA 79, 3843–3847.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Humana Press
About this protocol
Cite this protocol
Ma, F., Gu, Y., Nishihama, N., Yang, W., Yasuhiro, E., Tsuji, K. (2011). Differentiation of Human Embryonic and Induced Pluripotent Stem Cells into Blood Cells in Coculture with Murine Stromal Cells. In: Ye, K., Jin, S. (eds) Human Embryonic and Induced Pluripotent Stem Cells. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1007/978-1-61779-267-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-61779-267-0_23
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-266-3
Online ISBN: 978-1-61779-267-0
eBook Packages: Springer Protocols